The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cognitive impairment in incident, untreated Parkinson disease: The Norwegian ParkWest Study
Abstract
BACKGROUND: Little is known regarding the cognitive impairment in subjects with early, drug-naïve Parkinson disease (PD). The aim of this study was to explore the proportion with mild cognitive impairment (MCI) and subtypes in an incidence cohort of untreated PD in Southern and Western Norway. METHODS: A total of 196 non-demented, drug-naive patients who were recruited after an extensive search of all new cases of PD in the area and 201 healthy control subjects completed a battery of neuropsychological tests of verbal memory, visuospatial, and attentional-executive functioning. Subjects were classified as MCI if the age- and education-corrected z-score was falling 1.5 standard deviations below the mean for at least one of the cognitive domains. RESULTS: The PD group was more impaired on all neuropsychological tests than controls, but the effect sizes were small. The largest effect size was found for verbal memory. A total of 18.9% of the patients with PD were classified as MCI, with a relative risk of 2.1 (1.2-3.6) in PD compared to the control group. Patients with PD with and without MCI did not differ significantly regarding demographic and motor features. Among PD-MCI patients, nearly two-thirds had a non-amnestic MCI subtype, and one third had an amnestic MCI subtype. CONCLUSIONS: The findings demonstrate a twofold increase in the proportion with cognitive impairment in subjects with early, untreated Parkinson disease (PD) compared to controls. This has implications for diagnosis and management of PD. AD = Alzheimer disease; aMCI-MD = amnestic multiple-domain MCI; aMCI-SD = amnestic single-domain MCI; CVLT-2 = California Verbal Learning Test II; IQCode = Informant Questionnaire on Cognitive decline in the elderly; MADRS = Montgomery and Aasberg Depression Rating Scale; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; naMCI-MD = non-amnestic multiple-domain MCI; naMCI-SD = non-amnestic single-domain MCI; PD = Parkinson disease; RR = relative risks; UPDRS = Unified Parkinson's Disease Rating Scale; VOSP = Visual Object and Space Perception Battery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mild cognitive impairment has been reported to be twice as common in PD as in people not affected by the disease (Aarsland et al. 2009).”
From The clinical symptoms of Parkinson's disease. (2016) · cites this paper as Aarsland et al. 2009
In the citing paper
“Mild cognitive impairment (MCI) is already present in about a quarter of patients with early PD.[12][13][14]”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [12]
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationDiagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
Dubois, B., Burn, D. J., Goetz, C. G., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D. W., Duyckaerts, C. J., Cummings, J., Gauthier, S. G., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,099
Self-citationCognitive profile of patients with newly diagnosed Parkinson disease
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005) · Neurology · doi:10.1212/01.wnl.0000180516.69442.95 · Cited by 1,007
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams‐Gray, C. H., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 935
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review
Jorm, A. F. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000390 · Cited by 823
Depression rating scales in Parkinson's disease: Critique and recommendations
Schrag, A. E., Barone, P., Brown, R. G., Leentjens, A. F. G., McDonald, W. M., STARKSTEIN, S. E., Weintraub, D. A., Poewe, W. H., Rascol, O., Sampaio, C., et al. (2007) · Movement Disorders · doi:10.1002/mds.21333 · Cited by 690
Research works printed but not linked: 2
- Delis DC Kramer JHEK Ober BA. CVLT-II. California Verbal Learning Test. Second Edition. Adult Version. San Antonio TX: The Psychological Corporation: Harcourt Assessment Inc;
- Emre M. Dementia associated with Parkinson’s disease. Lancet Neurol 2003;2:229–237.
Cited by
Sorted by citations
Items 501–600 of 620
Lucas‐Jiménez, O., Ibarretxe‐Bilbao, N., Diez, I. P., Peña, J., Tijero, B., Galdós, M., Murueta‐Goyena, A., Pino, R. D., Acera, M., Gómez‐Esteban, J. C., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020573 · Cited by 3
Carlisle, T. C., Fought, A. J., Olson, K. E., Lopez‐Esquibel, N., Simpson, A., Medina, L. D., & Holden, S. K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1200347 · Cited by 3
Impact of Parkinsonism comorbid depression on cognitive functions
Shehata, G. A., Farweez, H. M., Ali, A. M., Hassan, H. S., Tohamy, A. M., Mostafa, M., Ibrahim, M. A., Tarek, K., Elrashedy, A. A., Abdelnaby, R., et al. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00813-z · Cited by 3
Früherkennung der Parkinson-Krankheit
Mollenhauer, B., Sixel‐Döring, F., Storch, A., Schneider, C. B., Hilker, R., & Kalbe, E. (2013) · Der Nervenarzt · doi:10.1007/s00115-013-3756-1 · Cited by 3
REM Sleep Behavior Disorder: a Prodromal Synucleinopathy
Suescun, J., Ellmore, T. M., & Schiess, M. C. (2016) · Current Geriatrics Reports · doi:10.1007/s13670-016-0174-9 · Cited by 3
김지혜, Young-Sun, J., Chang, M.-S., Choi, S.-Y., & Kwon, O. D. (2011) · Journal of the Korean Neurological Association · Cited by 3
The psychometric properties of the lifetime experience questionnaire (LEQ) in older American adults
Gonzales, C. (2012) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 3
Interaction between cognition and gait in patients with Parkinson’s disease
Hausdorff, J. M., Zitser, J., Mirelman, A., & Giladi, N. (2015) · Oxford University Press eBooks · doi:10.1093/med/9780199681648.003.0008 · Cited by 3
Mirelman, A., Deutsch, J. E., & Hausdorff, J. M. (2014) · Virtual reality technologies for health and clinical applications · doi:10.1007/978-1-4939-0968-1_8 · Cited by 3
Many roads lead to Parkinson's disease
Ravina, B. M., & Aarsland, D. (2013) · Movement Disorders · doi:10.1002/mds.25325 · Cited by 3
Self-citationLitvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., & Weintraub, D. (2012) · Movement Disorders · doi:10.1002/mds.25119 · Cited by 3
Béchet, S., Leonard, M. V., Ademola, E., Fritz, J. V., & Krüger, R. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-03090-z · Cited by 2
Pradhan, G. N., Kingsbury, S. E., Cevette, M. J., Stepánek, J., & Caselli, R. J. (2026) · Brain Sciences · doi:10.3390/brainsci16010070 · Cited by 2
Improving Conversations about Parkinson's Dementia
Dobreva, I., Thomas, J., Marr, A., O’Connell, R., Roche, M., Hannaway, N., Dore, C., Rose, S., Liu, K., Bhome, R., et al. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14054 · Cited by 2
Is There a Better Way to Assess Parkinsonian Motor Symptoms?—Experimental and Modelling Approach
Nair, S. S., Muddapu, V. R., Sriram, M., Aditya, R., Gupta, R., & Chakravarthy, V. S. (2021) · Series in bioengineering · doi:10.1007/978-981-16-3056-9_10 · Cited by 3
Durán-Navarrete, M. J., Soto-Voitmann, M. J., Torres-Araneda, G., & Gutiérrez, L. L. (2024) · Revista de Neurología · doi:10.33588/rn.7808.2024049 · Cited by 2
Yavuz, B., Rusen, E., Duman, T., & Bas, B. (2023) · Neurocase · doi:10.1080/13554794.2024.2345404 · Cited by 2
Carli, S., Brugnano, L., & Caligiore, D. (2024) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2024.1386841 · Cited by 2
Zhang, Y., Chen, F., & Ren, F. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05392-y · Cited by 2
Mild cognitive impairment in Parkinson's disease
Adler, C. H. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70787-4 · Cited by 2
Neuropsychological Features of Early Cognitive Impairment in Parkinson’s Disease
Williams‐Gray, C. H., & Mason, S. (2012) · Advances in biological psychiatry · doi:10.1159/000331656 · Cited by 2
Tröster, A. I., & Aarsland, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.016 · Cited by 2
Self-citationManagement of Nonmotor Symptoms of Parkinson's Disease
Gálvez-Jiménez, N., Fernandez, H. H., Espay, A. J., & Fox, S. H. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.010 · Cited by 2
Impulse Control Disorders in Parkinson’s disease
Erga, A. H. (2020) · Stavanger University Library eBooks · doi:10.31265/usps.39 · Cited by 2
Meyer, A., Handabaka, I., Ehrensperger, M. M., Gschwandtner, U., Hatz, F., Monsch, A. U., Stieglitz, R. D., & Fuhr, P. (2020) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000507757 · Cited by 2
Mirando, M., Penati, R., Godi, M., Giardini, M., & Nardone, A. (2024) · Brain Sciences · doi:10.3390/brainsci14040305 · Cited by 2
Temporal Aspects of Global Coherence during Discourse Production in Early Stage Parkinson’s Disease
Ellis, C., Fang, X., & Briley, P. M. (2016) · Advances in Parkinson s Disease · doi:10.4236/apd.2016.53006 · Cited by 2
Estimation of Cognitive Performance Based on Premorbid Intelligence in Parkinson’s Disease
Pino, R. D., Díez‐Cirarda, M., Peña, J., Ibarretxe‐Bilbao, N., & Ojeda, N. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202142 · Cited by 2
Nonmotor Problems in Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50011-5 · Cited by 2
Dillon, C., Leis, A., Castro, D. M., García, V., Zegarra, C., Leguizamon, P. P., Feldman, M. L., Laspiur, S. D., Viaggio, M. B., & Peralta, C. (2022) · Neurología Argentina · doi:10.1016/j.neuarg.2022.06.001 · Cited by 1
Li, R., & Zhuang, J. (2024) · Acta Neurologica Belgica · doi:10.1007/s13760-024-02710-x · Cited by 1
Tullo, E., Nair, G. R., & Henry, S. M. (2025) · Parkinson s Disease · doi:10.1155/padi/6636111 · Cited by 1
Visuospatial and visuoperceptual impairment in relation to global atrophy in Parkinson's disease
García-Díaz, A. I., Segura, B., Baggio, H. C., & Junqué, C. (2013) · Anuario de Psicología/The UB Journal of Psychology · Cited by 1
Idiopathisches Parkinson-Syndrom
Marxreiter, F., & Winkler, J. (2014) · Nervenheilkunde · doi:10.1055/s-0038-1627737 · Cited by 1
Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism
Wang, X.-H., Yang, J.-C., Soohoo, R., Cotter, D. L., Yuan, M., Xia, J., Yaqub, S., Doty, J., Niu, Y., Tassone, F., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00327 · Cited by 1
Cognitive Impairment and Dementia in Parkinson's Disease
Elkurd, M. T., & Dewey, R. B. (2020) · Psychiatric Annals · doi:10.3928/00485713-20200206-01 · Cited by 1
Neuropsychiatric aspects of the on/off phenomenon
Rektorová, I., & Baláž, M. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.024 · Cited by 1
Thuesen, J., Mikkelsen, T. B., Juel, K., Backmann, T., Winge, K., & Wæhrens, E. E. (2024) · Journal of Ageing and Longevity · doi:10.3390/jal4020009 · Cited by 1
The Effects of Neurofeedback Training in Patients with Parkinson’s Disease
da Paz, V. K. C., Tavares, M. C. H., & da Silva, W. I. S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006486 · Cited by 1
CFS Biomarkers in Parkinson’s Disease
Parnetti, L., Castrioto, A., De, C., Chiasserini, D., Tambasco, N., Rossi, A., Balducci, C., Beccari, T., & Calabresi, P. (2011) · InTech eBooks · doi:10.5772/16666 · Cited by 1
Yazdchi, M., Talebi, M., Aghbiglo, A. M., & Mashrabi, O. (2014) · Cited by 1
Senczyszyn, A., & Wallner, R. (2018) · Aktualności Neurologiczne · doi:10.15557/an.2018.0012 · Cited by 1
At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease
Weintraub, D. A., Hamilton, J. L., Eberling, J. L., & Litvan, I. (2018) · Movement Disorders · doi:10.1002/mds.27310 · Cited by 1
Characterization of cognition in mild cognitive impairment with and without Parkinson's disease
Auclair‐Ouellet, N., Mandl, S., Kibreab, M., Haffenden, A. M., Hanganu, A., Cheetham, J., Kathol, I., Sarna, J. R., Martino, D., & Monchi, O. (2020) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2020.100034 · Cited by 1
Nonmotor problems in Parkinson disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00008-1 · Cited by 1
Cognitive impairment and its association with cholinergic dysfunction in Parkinson’s disease
Baba, T., & Takeda, A. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12417 · Cited by 1
Dementia in Parkinson’s disease
Hu, M., & Baig, F. (2020) · doi:10.1093/med/9780198713005.003.0044 · Cited by 1
McLaughlin, J., & Young, T. (2021) · BJPsych Advances · doi:10.1192/bja.2021.67 · Cited by 1
Évolution démentielle chez un patient présentant une maladie de Parkinson idiopathique
Mollion, H., & Thobois, S. (2010) · Revue de neuropsychologie · doi:10.3917/rne.025.0013 · Cited by 1
Botta, R., Keshav, K. J., Kutty, B. M., Mahadevan, A., Pal, P. K., & Yadav, R. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_903_22 · Cited by 1
Cognitive and motor dysfunction in the early phase of Parkinson's disease
Domellöf, M. (2013) · DiVA at Umeå University (Umeå University) · Cited by 1
¿Es la atrofia del hipocampo en la enfermedad de Parkinson un predictor de demencia?
Ibarretxe‐Bilbao, N., & Junqué, C. (2011) · Alzheimer Realidades e investigación en demencia · doi:10.5538/1137-1242.2011.49.5 · Cited by 1
Lippa, C. F., & Possin, K. L. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch6 · Cited by 1
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.002 · Cited by 1
Self-citationThe role of dopamine in learning, movement & motivation
Shiner, T. (2012) · UCL Discovery (University College London) · Cited by 1
Structural brain MRI and cognition in newly diagnosed Parkinson’s disease
Dalaker, T. O. (2010) · NORA - Norwegian Open Research Archives
Pereira, J. B. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Lewy Body Dementia Spectrum (Alpha Synucleinopathies)
Taylor, J., & McKeith, I. G. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch58
Specific neuropsychiatric disorders
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.011
Self-citationYubero, R. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2011.10.003
Castro, E., Sportiello, M. T., & Cammisuli, D. M. (2014) · Journal of Aging and Gerontology · doi:10.12974/2309-6128.2014.02.02.5
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.019
Self-citationA neurobehavioralist approach to the management of cognitive impairment in Parkinson's disease
Tsai, P. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107284210.012
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.022
Self-citationParkinson’s disease: pathology, anatomy, and behavior
Burdick, D. J., & Leverenz, J. B. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.003
Affektive und kognitive Theory of Mind-Leistungen bei Patienten mit Basalganglien-Erkrankungen
Bodden, M. (2011) · open_UMR Marburg DSpace 10.0 (Philipps-Universität Marburg) · doi:10.17192/z2011.0066
Pharmacogenetics of Non-Motor Symptoms in Parkinson's Disease
Robertson, B. D. (2016) · Scholarship@Western (Western University)
Murphy, R. R., & Leverenz, J. B. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.019
The Lewy Body Dementias: Dementia with Lewy Bodies and Related Syndromes
Ptacek, S. G., Bernadotte, A., & Aarsland, D. (2017) · Springer eBooks · doi:10.1007/978-3-7091-1628-9_20
Self-citationPushpanathan, M. E. (2016) · UWA Profiles and Research Repository (University of Western Australia)
Dysphoria, dopaminergic medication and spatial memory in Parkinsons disease
Stankevich, Y., Thurm, F., Evens, R., Fauser, M., Riedel, O., Storch, A., Li, S. C., & Lueken, U. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000212
Glizer, D. (2017) · Scholarship@Western (Western University)
Cognitive Function in Early and Advanced Parkinson’s disease
Chen, L., & Wang, X. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000373
Management of non-motor symptoms of Parkinson‘s disease
Stacy, M. A. (2013) · doi:10.2217/ebo.13.122
Foster, E. R. (2018) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.7936/k7639p6h
EARLY RECOGNITION OF COGNITIVE ABILITY AND NUTRITIONAL MARKERS FOR DEMENTIA IN PARKINSON’S DISEASE
Håglin, L., Bäckman, L., Linder, J., Forsgren, L., & Domellöf, M. (2018) · Journal of Aging Research and Lifestyle · doi:10.14283/jarcp.2018.26
Shih, C.-H., Sklerov, M., Browner, N., & Dayan, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/542936
Hippocampal Neurogenesis in Neurodegenerative Movement Disorders
Kohl, Z., Winner, B., & Winkler, J. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-1908-6_5
‘Atypical’ Parkinson's disease – sporadic
Zeuner, K. E., & Berg, D. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.10.002
Cai, X. (2020) · Digital Repository Service (Northeastern University) · doi:10.17760/d20398331
CSF Biomarkers in Parkinson's disease
Parnetti, L., Castrioto, A., Carlo, C. D., Chiasserini, D., Tambasco, N., Rossi, A., Michiara, M., Beccari, T., & Calabresi, P. (2011)
파킨슨 경도인지장애와 피질하 혈관성 경도인지장애의 인지기능의 비교
김지혜, 진영선, Chang, M.-S., Choi, S.-Y., & Kwon, O. D. (2011)
Díez‐Cirarda, M., Ibarretxe‐Bilbao, N., Peña, J., & Ojeda, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-48382-1_7
Nonmotor problems in Parkinson disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C. L., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00008-1
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00004-4
Narayanan, N. S., & Albin, R. L. (2022) · Progress in brain research · doi:10.1016/s0079-6123(22)00076-0
Cognitive Dysfunction in Parkinson’s Disease
Salzman, D., & Tabish, S. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009039291.008
Hou, Y., Wei, Q., Ou, R., Zhang, L., Yuan, X., Gong, Q., & Shang, H. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.06.066
Qin, J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.211438
Mild Cognitive Impairment in Parkinson’s Disease
Martínez‐Horta, S., & Kulisevsky, J. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_2
Emerging Roles of TREM2 in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_7
Parkinsons Disease: Recent Advancement and Future Aspects
Indrakshi, T., Aparna, A., Krishna, H., Aashul, N., & Rajawat, J. S. (2022) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2022.47171
Accinni, T., Fanella, M., Frascarelli, M., Buzzanca, A., Kotzalidis, G. D., Putotto, C., Marino, B., Panzera, A., Moschillo, A., Pasquini, M., et al. (2023) · Acta Neurologica Scandinavica · doi:10.1155/2023/8546610
Longo, C., Romano, D., Pennacchio, M., Malaguti, M. C., Giacopo, R. D., Giometto, B., & Papagno, C. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4533598
Parkinson's disease and routine traffic stops: An exploration of patient experiences and perceptions
Irvine, R. E., Kruger, A. P., Quaicoe, A., Kotwani, R., Hohler, A. D., & Vaou, O. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251356514
The Effect of Cognitive Impairments in Parkinson’s Disease on Caregiver Burden
Kıcıklar, S. (2025) · IBAD Sosyal Bilimler Dergisi · doi:10.21733/ibad.1700404
Golesorkhi, N., Leta, V., Chaudhuri, К. R., & Walker, N. F. (2025) · International Neurourology Journal · doi:10.5213/inj.2550094.047
Choudhury, A. R., Halder, S., & Mahato, A. K. (2025) · Industrial Psychiatry Journal · doi:10.4103/ipj.ipj_30_25
Ramezani, F., Mahmoudi, S., & Safari, F. (2025) · eNeurologicalSci · doi:10.1016/j.ensci.2025.100599
Metadata
- Authors
- Aarsland, D., Brønnick, K., Larsen, J. P., Tysnes, O. B., & Alves, G.
- Affiliations
- Stavanger University Hospital (NO)
- From The Norwegian Centre for Movement Disorders (D.A., K.B., J.P.L., G.A.), Department of Neurology (J.P.L., G.A.), and Department of Psychiatry (D.A.), Stavanger University Hospital, Stavanger; Department of Neurology (O.B.T.), Haukeland University Hospital, Bergen; and School of Medicine (D.A., J.P.L., O.B.T.), University of Bergen, Norway.
- Venue
- Neurology
- Published
- 2009-03-31
- Volume
- 72
- Issue
- 13
- Pages
- 1121-1126
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2120049868
- Cited by
- 625
- References
- 25
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 24 · 2023: 19 · 2022: 33 · 2021: 34 · 2020: 33 · 2019: 39 · 2018: 34 · 2017: 44 · 2016: 43 · 2015: 40 · 2014: 40 · 2013: 53 · 2012: 48
- FWCI
- 22.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Parkinson's disease, mild cognitive impairment, early-stage Parkinson's disease, amnestic MCI, non-amnestic MCI, verbal memory impairment, executive function, visuospatial ability, attention, prevalence of cognitive impairment
- MeSH terms
- Aged, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Norway, Parkinson Disease, Prospective Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review